This website requires Javascript for some parts to function propertly. Your experience may vary.

Hengeler Mueller advises Novonesis in the context of the acquisition of dsm-firmenich's share of the Feed Enzyme Alliance | Hengeler Mueller News

Hengeler Mueller advises Novonesis in the context of the acquisition of dsm-firmenich's share of the Feed Enzyme Alliance

Novonesis has entered into an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and purchase its sales and distribution activities in exchange for a total cash consideration of EUR 1.5 billion. The transaction follows more than 25 years of successful collaboration between the parties. The acquisition aligns with Novonesis' strategic ambitions to expand its presence across the animal biosolutions value chain.

Hengeler Mueller has advised Novonesis regarding the Feed Enzyme Alliance Agreement in the context of the transaction.

Hengeler Mueller team for Novonesis

Daniel Engel (partner), Viola de Blecourt (senior associate, both Munich).

Latest Articles

Hengeler Mueller advises EQT on long-term strategic partnership with WTS following investment from EQT X

Hengeler Mueller advises LifeFit Group in connection with the financing of the acquisition of FIT/One Group

Hengeler Mueller advises DOUGLAS Group in connection with partial refinancing by German private placement in the amount of €200m

Recent Dispute Resolution Work